DrugPatentWatch Database Preview
Details for Patent: 7,687,516
Which drugs does patent 7,687,516 protect, and when does it expire?
Patent 7,687,516 protects ARGATROBAN IN SODIUM CHLORIDE and is included in one NDA.
This patent has seven patent family members in five countries.
Summary for Patent: 7,687,516
| Title: | Alcohol free formulation of argatroban |
| Abstract: | An aqueous formulation of argatroban and of related compounds is disclosed along with a reconstitutable formulation, each of which is substantially, if not totally alcohol free. The formulations are also substantially free, if not totally free, of mono-, di-, and oligo-saccharides. An especially preferred embodiment is a ready-to-administer 1 mg/ml injectable dosage form having argatroban, lactobionic acid, and methionine. |
| Inventor(s): | Palepu; Nageswara R. (Southampton, PA) |
| Assignee: | Eagle Pharmaceuticals, Inc. (Woodcliff Lake, NJ) |
| Application Number: | 11/973,485 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,687,516 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Use; Composition; |
Drugs Protected by US Patent 7,687,516
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eagle Pharms | ARGATROBAN IN SODIUM CHLORIDE | argatroban | INJECTABLE;INTRAVENOUS | 022434-001 | Jun 29, 2011 | RX | Yes | Yes | Start Trial | Start Trial | Y | METHOD OF TREATING AN ARGATROBAN TREATABLE CONDITION | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,687,516
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2669727 | Start Trial | |||
| China | 101516370 | Start Trial | |||
| European Patent Office | 2083823 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
